Download PDF

Other users also viewed these articles

Prevalence and Determinants of COPD in Spain: EPISCAN II Joan B. Soriano; Inmaculada Alfageme; Marc Miravitlles; Pilar de Lucas; Juan José Soler-Cataluña; Francisco García-Río; Ciro Casanova; José Miguel Rodríguez González-Moro; Borja G. Cosío; Guadalupe Sánchez; Julio Ancochea;
Arch Bronconeumol. 2021;57:61-9
Metabolic Changes After Bronchoscopic Lung Volume Reduction With Endobronchial Valves in COPD Patients Marieke C. van der Molen; Rein Posthuma; Anouk W. Vaes; Martijn A. Spruit; Harry R. Gosker; Alain R. Viddeleer; Tineke P. Willems; Lowie E.G.W. Vanfleteren; Dirk-Jan Slebos; Jorine E. Hartman;
Arch Bronconeumol. 2025;61:282-9
N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses Alberto Papi; Franco Alfano; Tommaso Bigoni; Lorenzo Mancini; Amal Mawass; Federico Baraldi; Cristina Aljama; Marco Contoli; Marc Miravitlles;
Arch Bronconeumol. 2024;60:269-78